Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
31st Dec 21 Source: CRO
- €2 billion turnover
-
-€698.3 million
profit - 2,800 employees
-
25th Dec 20 Source: CRO
- €1.8 billion turnover
-
-€814.7 million
profit - 3,289 employees
- 5 more years available »
Ranking
By Turnover
(€2 billion)- 57th in Top Companies
By Employees
(2,800)- 87th in Top Companies
- 2,800
- €2 billion
Employees
- David Keenan Vice President}
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears